RAM
TEVA icon

Resona Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Resona Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Sell
316,361
-15,736
-5% -$524K 0.05% 310
2026
Q1 		$9.92M Buy
332,097
+3,653
+1% +$118K 0.05% 315
2025
Q4 		$10.3M Sell
328,444
-21,374
-6% -$527K 0.05% 312
2025
Q3 		$7.02M Sell
349,818
-10,498
-3% -$184K 0.03% 420
2025
Q2 		$6.04M Buy
360,316
+18,093
+5% +$292K 0.03% 466
2025
Q1 		$5.25M Buy
342,223
+16,302
+5% +$291K 0.03% 454
2024
Q4 		$7.21M Sell
325,921
-3,253
-1% -$59.2K 0.04% 369
2024
Q3 		$5.91M Sell
329,174
-9,891
-3% -$173K 0.03% 431
2024
Q2 		$5.51M Sell
339,065
-25,431
-7% -$392K 0.03% 430
2024
Q1 		$5.14M Buy
+364,496
New +$4.59M 0.03% 477

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Resona Asset Management's TEVA Position: Q2 2026 in Review

Resona Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 4.7% in Q2 2026, selling an estimated $524K and leaving 316,361 shares worth $10.7M. The position accounts for 0.05% of the portfolio, ranked #310.

Resona Asset Management first reported a position in TEVA in Q1 2024 and has held it in 10 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Resona Asset Management held 316,361 shares of Teva Pharmaceuticals worth $10.7M as of Q2 2026.
  • Resona Asset Management sold 15,736 Teva Pharmaceuticals shares in Q2 2026, an estimated $524K.
  • Teva Pharmaceuticals made up 0.05% of Resona Asset Management's portfolio in Q2 2026, its #310 holding.
  • Resona Asset Management first reported a position in Teva Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.